Conflicts of interest

21 U.S. Code § 379d-1. Conflicts of interest

(a) DefinitionsFor purposes of this section:
(1) Advisory committee
The term “advisory committee” means an advisory committee under chapter 10 of title 5 that provides advice or recommendations to the Secretary regarding activities of the Food and Drug Administration.
(2) Financial interest
The term “financial interest” means a financial interest under section 208(a) of title 18.
(b) Recruitment for advisory committees
(1) In generalThe Secretary shall—
(A)
develop and implement strategies on effective outreach to potential members of advisory committees at universities, colleges, other academic research centers, professional and medical societies, and patient and consumer groups;
(B)
seek input from professional medical and scientific societies to determine the most effective informational and recruitment activities;
(C) at least every 180 days, request referrals for potential members of advisory committees from a variety of stakeholders, including—
(i)
product developers, patient groups, and disease advocacy organizations; and
(ii) relevant—
(I)
professional societies;
(II)
medical societies;
(III)
academic organizations; and
(IV)
governmental organizations; and
(D)
in carrying out subparagraphs (A) and (B), take into account the levels of activity (including the numbers of annual meetings) and the numbers of vacancies of the advisory committees.
This document is only available to subscribers. Please log in or purchase access.